Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease

被引:214
|
作者
Vivante, Asaf [1 ,2 ]
Golan, Eliezer [2 ,3 ]
Tzur, Dorit
Leiba, Adi [2 ]
Tirosh, Amir [7 ]
Skorecki, Karl [4 ,5 ]
Calderon-Margalit, Ronit [6 ]
机构
[1] Edmond & Lily Safra Childrens Hosp, Israeli Def Forces Med Corps, Chaim Sheba Med Ctr, Dept Pediat,Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Israel Renal Registry, Bristol, Avon, England
[4] Technion Israel Inst Technol, Rappaport Fac Med, Dept Nephrol, Haifa, Israel
[5] Technion Israel Inst Technol, Res Inst, Haifa, Israel
[6] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth, Jerusalem, Israel
[7] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
关键词
OBESITY-RELATED GLOMERULOPATHY; US CHILDREN; KIDNEY-DISEASE; UNITED-STATES; FOLLOW-UP; PREVALENCE; OVERWEIGHT; POPULATION; PROTEINURIA; ASSOCIATION;
D O I
10.1001/2013.jamainternmed.85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD. Methods: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification. Results: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (>= 95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented. Conclusions: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.
引用
收藏
页码:1644 / 1650
页数:7
相关论文
共 50 条
  • [31] Body Fluids in End-Stage Renal Disease: Statics and Dynamics
    Kooman, Jeroen P.
    van der Sande, Frank M.
    BLOOD PURIFICATION, 2019, 47 (1-3) : 223 - 229
  • [32] Body composition and physical activity in end-stage renal disease
    Majchrzak, Karen M.
    Pupim, Lara B.
    Sundell, Mary
    Ikizler, T. Alp
    JOURNAL OF RENAL NUTRITION, 2007, 17 (03) : 196 - 204
  • [33] Body Mass Index (BMI) Correlates Poorly with Visceral Adiposity in End-Stage Liver Disease
    Patwa, Laura
    Stanich, Peter P.
    Booty, Jordan
    Michaels, Anthony
    Kirkpatrick, Robert B.
    Hanje, James
    Barker, Samantha
    Porter, Kyle
    Levin, Douglas M.
    HEPATOLOGY, 2013, 58 : 769A - 769A
  • [34] Growth Following Renal Transplantation in Children and Adolescents with End-Stage Renal Disease
    Andrade, M. C.
    Mangia, C.
    Abreu Carvalhaes, J. T.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1811 - 1811
  • [35] Changes of Left Ventricular Mass Index Among End-Stage Renal Disease Patients After Renal Transplantation
    Namazi, Mohammad Hassan
    Parsa, Saeed Alipour
    Hosseini, Banafshe
    Saadat, Habibollah
    Safi, Morteza
    Motamedi, Mohammad Reza
    Vakili, Hossein
    UROLOGY JOURNAL, 2010, 7 (02) : 105 - 109
  • [36] Human fetuin-A levels and calcification risk index as novel indicators of cardiovascular disease and mortality in end-stage liver disease and end-stage renal disease.
    Nilson, NM
    Mullaney, S
    Thistlethwaite, P
    Gao, P
    Herold, D
    Wolf, P
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (03) : 462 - 463
  • [37] Quality of life of adolescents with end-stage renal disease and kidney transplant
    Isolina Riaño-Galán
    Serafín Málaga
    Luis Rajmil
    Gema Ariceta
    Mercedes Navarro
    Cesar Loris
    Alfredo Vallo
    Pediatric Nephrology, 2009, 24 : 1561 - 1568
  • [38] Hepatitis C infection in children and adolescents with end-stage renal disease
    Molle, ZL
    Baqi, N
    Gretch, D
    Hidalgo, G
    Tejani, A
    Rabinowitz, SS
    PEDIATRIC NEPHROLOGY, 2002, 17 (06) : 444 - 449
  • [39] Predictive value of cardio-ankle vascular index for the risk of end-stage renal disease
    Jeong, Jin Seon
    Kim, Jung Hee
    Kim, Dong Ki
    Oh, Kook-Hwan
    Joo, Kwon-Wook
    Kim, Yon Su
    Cho, Young Min
    Han, Seung Seok
    CLINICAL KIDNEY JOURNAL, 2021, 14 (01) : 255 - 260
  • [40] Hepatitis C infection in children and adolescents with end-stage renal disease
    Zarela L. Molle
    Noosha Baqi
    David Gretch
    Guillermo Hidalgo
    Amir Tejani
    S. S. Rabinowitz
    Pediatric Nephrology, 2002, 17 : 444 - 449